The ABCs of SDOH: Meaningful strategies to improve patient outcomes

BioPharma Dive May 20, 2024
Meg Richards, PhD, MPH, Executive Director, Scientific Strategy at Panalgo, with Andrew Goldstein, VP of Client Partnerships at Panalgo

In the ever-evolving healthcare landscape, social determinants of health (SDOH) are pivotal factors in influencing patient outcomes. As biopharmaceutical and medical device companies increasingly recognize the impact of SDOH, a question emerges: how can these sponsors effectively integrate SDOH data into clinical trial recruitment and real-world evidence strategies? To find out, I spoke with Andrew Goldstein, VP of Client Partnerships at Panalgo, to discuss the core strategies and considerations essential for harnessing SDOH to drive meaningful improvements in patient care.

Q: More and more, biopharmaceutical and medical device companies are realizing the importance of SDOH, but they’re not quite sure how to incorporate SDOH into their data lake and research strategies. What’s your advice for getting started?

If you don’t...

Today's Sponsors

Today's Sponsor